State Street’s ENvue Medical Inc FEED Stock Holding History

State Street’s Portfolio FEED Stock Details FEED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-57	Closed	-$31.3K	–	4807
2022 Q4	$31.3K	Hold	57	–	–	﹤0.01%	4661
2022 Q3	$58K	Hold	57	–	–	﹤0.01%	4625
2022 Q2	$77K	Hold	57	–	–	﹤0.01%	4616
2022 Q1	$145K	Buy	57 +14	+33%	+$26.4K	﹤0.01%	4509
2021 Q4	$99K	Hold	43	–	–	﹤0.01%	4584
2021 Q3	$195K	Buy	43 +24	+126%	+$106K	﹤0.01%	4366
2021 Q2	$35K	Buy	+19	New	+$38.4K	﹤0.01%	4456

Other funds holding FEED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFS

Amtrust Financial Services New York $300M AUM 12.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NewSquare Capital Newtown Square, Pennsylvania $1.15B AUM 24.78% 1-Year Est. Return

State Street's FEED Position: Q1 2023 in Review

State Street sold out of ENvue Medical Inc (FEED) in Q1 2023, closing a stake of 57 shares — an estimated $31.3K sold.

State Street first reported a position in FEED in Q2 2021 and held it in 7 quarters. The position peaked at $195K in Q3 2021. 7 funds tracked by Wall St. Rank hold FEED as of Q1 2023.

State Street reported no remaining ENvue Medical Inc position as of Q1 2023 after selling out during the quarter.
State Street sold 57 ENvue Medical Inc shares in Q1 2023, an estimated $31.3K.
State Street first reported a position in ENvue Medical Inc in Q2 2021 and held it in 7 quarters.
State Street's ENvue Medical Inc position peaked at $195K in Q3 2021.
7 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.